Natera and Eledon partner on kidney transplant Phase 3 trial
Go back to Natera and Eledon partner on kidney transplant Phase 3 trial| (NASDAQ: ELDN) | Delayed: 2.78 -0.04 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.82 | 52 Week High | $ | |||
| Open | $2.78 | 52 Week Low | $ | |||
| Day High | $2.81 | P/E | N/A | |||
| Day Low | $2.75 | EPS | $ | |||
| Volume | 744,152 | |||||
| (NASDAQ: NTRA) | Delayed: 326.14 -4.17 (1.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $330.31 | 52 Week High | $13.80 | |||
| Open | $324.92 | 52 Week Low | $6.52 | |||
| Day High | $331.19 | P/E | N/A | |||
| Day Low | $320.65 | EPS | $0.00 | |||
| Volume | 1,070,019 | |||||
